de Jong, Henriėtte M Y <br/><br/>
Sustained remission with methotrexate monotherapy after 22-week induction treatment with TNF-alpha inhibitor and methotrexate in early psoriatic arthritis: an open-label extension of a randomized placebo-controlled trial.  [electronic resource] 

 -  Arthritis research & therapy  09 2019 
 - 208 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1478-6362 
<br/><br/><label>Standard No.: </label>10.1186/s13075-019-1998-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--administration & dosage<br/>Antirheumatic Agents--administration & dosage<br/>Arthritis, Psoriatic--diagnosis<br/>Disease Progression<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Remission Induction--methods<br/>Time Factors<br/>Treatment Outcome<br/>Tumor Necrosis Factor Inhibitors--therapeutic use